Goals

  • Provide a forum for networking and communication between international researchers in rheumatology and dermatology, industry, patient service leagues, and regulatory agencies
  • Provide the opportunity for in-person meetings and online communication to share knowledge, research findings, and develop or conduct collaborative research, education and other projects
  • Develop and validate a criteria set for the definition of psoriatic arthritis (PsA)
  • Review, develop and validate effective and feasible outcome measures for the assessment of PsA and psoriasis (PsO)
  • Promote the development of national and international collaborative registries of PsA and PsO patients to standardize the data being obtained and learn more about the natural history of the disease as well as its genetic underpinnings
  • Work closely with representatives of patient service leagues to promote public education and awareness of PsA and PsO
  • Work closely with representatives of member biopharmaceutical companies to promote and conduct research on effective therapies for PsA and PsO
  • Reach out to representatives of regulatory agencies to establish appropriate guidelines for regulatory approval of new therapies
  • Work with other professional organizations, such as the American College of Rheumatology, American Academy of Dermatology, and OMERACT to promote knowledge of research about PsA and PsO within the context of those disciplines
  • Develop and maintain current Treatment Guidelines for psoriatic arthritis